SLAM
SLS icon

Swiss Life Asset Management’s SELLAS Life Sciences SLS Stock Holding History

Swiss Life Asset Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179K Buy
+12,124
New +$83.7K ﹤0.01% 1545

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

Swiss Life Asset Management's SLS Position: Q2 2026 in Review

Swiss Life Asset Management opened a new position in SELLAS Life Sciences (SLS) in Q2 2026: 12,124 shares worth $179K. The stake represents ﹤0.01% of the portfolio and ranks #1545 among its holdings.

118 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Swiss Life Asset Management held 12,124 shares of SELLAS Life Sciences worth $179K as of Q2 2026.
  • SELLAS Life Sciences was a new Swiss Life Asset Management position in Q2 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1545 holding.
  • 118 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.